SPARC Induces COL1A1/COL3A1 Expressions Representing Aggressive Molecular Cancer-Associated Fibroblasts Signatures

Yusuke Nie1, Yoshiki Fujiyama1, Shumpei Shibaki1

  • 1Division of Advanced Surgical Oncology, Research and Development Center for New Medical Frontiers, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.

PubMed
Abstract

Insights

Secreted protein, acidic and rich in cysteine (SPARC) promotes colorectal cancer metastasis by altering the tumor microenvironment (TME). Targeting SPARC and its associated genes offers potential therapeutic strategies for aggressive cancers.

Area of Science:

  • Oncology
  • Cancer Biology
  • Tumor Microenvironment Research

Background:

  • Secreted protein, acidic and rich in cysteine (SPARC) is implicated in tumor metastasis, but its precise role in the tumor microenvironment (TME) is not fully understood.
  • Stromal overexpression of SPARC may indicate colorectal cancer (CRC) progression.

Purpose of the Study:

  • To investigate the clinical and functional significance of SPARC in colorectal cancer (CRC) metastasis.
  • To elucidate the molecular mechanisms by which SPARC influences the tumor microenvironment (TME).

Main Methods:

  • Exploration of SPARC molecular status in CRC tumors.
  • SPARC knockdown in cancer-associated fibroblasts (CAFs).
  • Analysis of gene expression (COL1A1/COL3A1, secretome genes) and the CSF1/CSF1R axis.

Main Results:

  • SPARC expression is specific to CRC stroma and has prognostic value.
  • SPARC knockdown in CAFs reduced metastatic phenotypes and suppressed COL1A1/COL3A1 and secretome genes.
  • The CSF1/CSF1R axis is crucial for SPARC-driven cancer invasion.
  • CAF-associated genes (CAFGs), including COL genes, are prognostic indicators.

Conclusions:

  • SPARC promotes metastasis by inducing collagen and secretome genes in the TME, acting detrimentally to the host.
  • These findings enhance understanding of aggressive TME and identify potential therapeutic targets for cancer metastasis.

Related Concept Videos

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.4K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.4K